Sign in
4

Changes in Ownership

ANAPTYSBIO, INC Filed Acc 0001209191-23-049810

Chief Medical Officer sold 2,105 shares at $19.48 ($41,005)

  • Chief Medical Officer acquired 6,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Lizzul Paul F. · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-09-14 Exercise or conversion : show line 1 in the form +6,000 8,632 D
2023-09-14 Sale : show line 2 in the form −2,105 $19.48 $41,005 6,527 D
Open-market sales · 2,105 sh · avg $19.48 · $41,005

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-09-14 Exercise or conversion : show line 3 in the form Restricted Stock Unit −6,000 6,000 D
Loading xslF345X05/doc4.xml…